{"#title":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment","#attached":{"library":["mqis\/reports"],"drupalSettings":{"mqis":{"measures":{"117322":{"xcomps":{"2023":"2023"},"ycomps":{"2023":{"0":"65.6","4":"68.4","8":"78.0"}},"complegend":{"0":"New England Medicaid Managed Care CY 2023","4":"National Medicaid Managed Care 75th Percentile CY 2023","8":"NH Commercial CY 2023"},"compdata":{"Comparison Rate":[{"name":"New England Medicaid Managed Care","data_source":"New England Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"2","notes":"","year":"2023","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"New England Medicaid Managed Care","data_source":"New England Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"2","notes":"","year":"2023","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"New England Medicaid Managed Care","data_source":"New England Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"2","notes":"","year":"2022","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"New England Medicaid Managed Care","data_source":"New England Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"2","notes":"","year":"2021","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"New England Medicaid Managed Care","data_source":"New England Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"2","notes":"","year":"2020","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"New England Medicaid Managed Care","data_source":"New England Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"2","notes":"","year":"2020","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"National Medicaid Managed Care 75th Percentile","data_source":"National Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"3","notes":"","year":"2023","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"National Medicaid Managed Care 75th Percentile","data_source":"National Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"3","notes":"","year":"2023","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"National Medicaid Managed Care 75th Percentile","data_source":"National Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"3","notes":"","year":"2022","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"National Medicaid Managed Care 75th Percentile","data_source":"National Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"3","notes":"","year":"2021","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"National Medicaid Managed Care 75th Percentile","data_source":"National Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"3","notes":"","year":"2020","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"National Medicaid Managed Care 75th Percentile","data_source":"National Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"3","notes":"","year":"2020","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"NH Commercial","data_source":"NH Commercial","data_source_order":"14","notes":"","year":"2023","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"NH Commercial","data_source":"NH Commercial","data_source_order":"14","notes":"","year":"2023","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"NH Commercial","data_source":"NH Commercial","data_source_order":"14","notes":"","year":"2022","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"NH Commercial","data_source":"NH Commercial","data_source_order":"14","notes":"","year":"2021","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"NH Commercial","data_source":"NH Commercial","data_source_order":"14","notes":"","year":"2020","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"NH Commercial","data_source":"NH Commercial","data_source_order":"14","notes":"","year":"2020","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"}]},"ymax":115,"comp_table":"\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
Antidepressant Medication Management (AMM): Effective Acute Phase Treatment - Comparators (Export<\/a>)<\/span><\/caption>\n \n \n
Original Order\n \n Sort descending\n <\/span>\n<\/span>\n<\/a><\/th>\n Measure ID<\/a><\/th>\n Measure Name<\/a><\/th>\n Comparator Name<\/a><\/th>\n Comparator Type<\/a><\/th>\n Year<\/a><\/th>\n Value<\/a><\/th>\n <\/tr>\n <\/thead>\n \n
0<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n New England Medicaid Managed Care CY 2023<\/td>\n Comparison Rate<\/td>\n 2023<\/td>\n \u2021<\/td>\n <\/tr>\n
1<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n New England Medicaid Managed Care CY 2022<\/td>\n Comparison Rate<\/td>\n 2022<\/td>\n \u2021<\/td>\n <\/tr>\n
2<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n New England Medicaid Managed Care CY 2021<\/td>\n Comparison Rate<\/td>\n 2021<\/td>\n \u2021<\/td>\n <\/tr>\n
3<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n New England Medicaid Managed Care CY 2020<\/td>\n Comparison Rate<\/td>\n 2020<\/td>\n \u2021<\/td>\n <\/tr>\n
4<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n National Medicaid Managed Care 75th Percentile CY 2023<\/td>\n Comparison Rate<\/td>\n 2023<\/td>\n \u2021<\/td>\n <\/tr>\n
5<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n National Medicaid Managed Care 75th Percentile CY 2022<\/td>\n Comparison Rate<\/td>\n 2022<\/td>\n \u2021<\/td>\n <\/tr>\n
6<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n National Medicaid Managed Care 75th Percentile CY 2021<\/td>\n Comparison Rate<\/td>\n 2021<\/td>\n \u2021<\/td>\n <\/tr>\n
7<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n National Medicaid Managed Care 75th Percentile CY 2020<\/td>\n Comparison Rate<\/td>\n 2020<\/td>\n \u2021<\/td>\n <\/tr>\n
8<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n NH Commercial CY 2023<\/td>\n Comparison Rate<\/td>\n 2023<\/td>\n 78.0<\/td>\n <\/tr>\n
9<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n NH Commercial CY 2022<\/td>\n Comparison Rate<\/td>\n 2022<\/td>\n 77.2<\/td>\n <\/tr>\n
10<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n NH Commercial CY 2021<\/td>\n Comparison Rate<\/td>\n 2021<\/td>\n 81.0<\/td>\n <\/tr>\n
11<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n NH Commercial CY 2020<\/td>\n Comparison Rate<\/td>\n 2020<\/td>\n 70.0<\/td>\n <\/tr>\n <\/tbody>\n <\/table>\n","xseries":{"2015":"2015","2016":"2016","2017":"2017","2018":"2018","2019":"2019","2020":"2020","2021":"2021","2022":"2022","2023":"2023","2024":"2024"},"yseries":{"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment":{"2015":"58.9","2016":"56.6","2017":"57.4","2018":"54.7","2019":"60.7","2020":"61.0","2021":"65.2","2022":"66.4","2023":"66.6","2024":"69.3"}},"trendlegend":{"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment":"Total (All Subgroups)"},"numerators":{"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment":[1059,957,742,682,1125,1914,2647,2397,1596,1203]},"denominators":{"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment":[1799,1691,1293,1246,1852,3136,4062,3611,2395,1737]},"timeperiods":{"t_2015-01-01_2015-12-31":{"start":"1420088400","end":"1451538000"},"t_2016-01-01_2016-12-31":{"start":"1451624400","end":"1483160400"},"t_2017-01-01_2017-12-31":{"start":"1483246800","end":"1514696400"},"t_2018-01-01_2018-12-31":{"start":"1514782800","end":"1546232400"},"t_2019-01-01_2019-12-31":{"start":"1546318800","end":"1577768400"},"t_2020-01-01_2020-12-31":{"start":"1577854800","end":"1609390800"},"t_2021-01-01_2021-12-31":{"start":"1609477200","end":"1640926800"},"t_2022-01-01_2022-12-31":{"start":"1641013200","end":"1672462800"},"t_2023-01-01_2023-12-31":{"start":"1672549200","end":"1703998800"},"t_2024-01-01_2024-12-31":{"start":"1704085200","end":"1735621200"}},"data_elements":[{"data_element_id":"261044","identifier":"HEDIS_AMM.01.A_NUM","measure_id":"120419","type":"1","tech_definition":"

See HEDIS\u00ae Technical Specifications for Health Plans Volume 2 for the relevant measurement year.<\/p>","class":"1","uploader_user_id":"51","last_modified":"1705426429","spec_id":"836","data_element_class_name":"Numerator"},{"data_element_id":"261045","identifier":"HEDIS_AMM.01.A_DEN","measure_id":"120419","type":"1","tech_definition":"

See HEDIS\u00ae Technical Specifications for Health Plans Volume 2 for the relevant measurement year.<\/p>","class":"2","uploader_user_id":"51","last_modified":"1705426443","spec_id":"836","data_element_class_name":"Denominator"},{"data_element_id":"261046","identifier":"HEDIS_AMM.01.A_RATE","measure_id":"120419","type":"1","tech_definition":"

See HEDIS\u00ae Technical Specifications for Health Plans Volume 2 for the relevant measurement year.<\/p>","class":"3","uploader_user_id":"51","last_modified":"1705426457","spec_id":"836","data_element_class_name":"Rate"},{"data_element_id":"261047","identifier":"HEDIS_AMM.01.A_LCI","measure_id":"120419","type":"1","tech_definition":"

See HEDIS\u00ae Technical Specifications for Health Plans Volume 2 for the relevant measurement year.<\/p>","class":"4","uploader_user_id":"51","last_modified":"1705426471","spec_id":"836","data_element_class_name":"Lower Confidence Interval"},{"data_element_id":"261048","identifier":"HEDIS_AMM.01.A_UCI","measure_id":"120419","type":"1","tech_definition":"

See HEDIS\u00ae Technical Specifications for Health Plans Volume 2 for the relevant measurement year.<\/p>","class":"5","uploader_user_id":"51","last_modified":"1705426483","spec_id":"836","data_element_class_name":"Upper Confidence Interval"}],"data_table":"\n \n \n \n \n \n \n \n \n \n \n \n \n \n
Antidepressant Medication Management (AMM): Effective Acute Phase Treatment (Export<\/a>)<\/span><\/caption>\n \n \n
Time Period<\/th>\n Measure Name<\/th>\n Measure Numerator<\/th>\n Measure Denominator<\/th>\n Measure Rate<\/th>\n Confidence Interval<\/th>\n <\/tr>\n <\/thead>\n \n
2015-01-01 - 2015-12-31<\/td>\n Total (All Subgroups)<\/td>\n 1,059<\/td>\n 1,799<\/td>\n 58.9%<\/td>\n 56.6 - 61.2<\/td>\n <\/tr>\n
2016-01-01 - 2016-12-31<\/td>\n Total (All Subgroups)<\/td>\n 957<\/td>\n 1,691<\/td>\n 56.6%<\/td>\n 54.2 - 59.0<\/td>\n <\/tr>\n
2017-01-01 - 2017-12-31<\/td>\n Total (All Subgroups)<\/td>\n 742<\/td>\n 1,293<\/td>\n 57.4%<\/td>\n 54.7 - 60.1<\/td>\n <\/tr>\n
2018-01-01 - 2018-12-31<\/td>\n Total (All Subgroups)<\/td>\n 682<\/td>\n 1,246<\/td>\n 54.7%<\/td>\n 51.9 - 57.5<\/td>\n <\/tr>\n
2019-01-01 - 2019-12-31<\/td>\n Total (All Subgroups)<\/td>\n 1,125<\/td>\n 1,852<\/td>\n 60.7%<\/td>\n 58.5 - 62.9<\/td>\n <\/tr>\n
2020-01-01 - 2020-12-31<\/td>\n Total (All Subgroups)<\/td>\n 1,914<\/td>\n 3,136<\/td>\n 61.0%<\/td>\n 59.3 - 62.7<\/td>\n <\/tr>\n
2021-01-01 - 2021-12-31<\/td>\n Total (All Subgroups)<\/td>\n 2,647<\/td>\n 4,062<\/td>\n 65.2%<\/td>\n 63.7 - 66.7<\/td>\n <\/tr>\n
2022-01-01 - 2022-12-31<\/td>\n Total (All Subgroups)<\/td>\n 2,397<\/td>\n 3,611<\/td>\n 66.4%<\/td>\n 64.9 - 67.9<\/td>\n <\/tr>\n
2023-01-01 - 2023-12-31<\/td>\n Total (All Subgroups)<\/td>\n 1,596<\/td>\n 2,395<\/td>\n 66.6%<\/td>\n 64.7 - 68.5<\/td>\n <\/tr>\n
2024-01-01 - 2024-12-31<\/td>\n Total (All Subgroups)<\/td>\n 1,203<\/td>\n 1,737<\/td>\n 69.3%<\/td>\n 67.1 - 71.5<\/td>\n <\/tr>\n <\/tbody>\n <\/table>\n","suppressed":false,"orgs":{"MCM: AmeriHealth Caritas NH":12,"MCM: NH Healthy Families":1,"MCM: Well Sense":3,"MCM: Meridian":2},"qualifiers":{"2015":[],"2016":[],"2017":[],"2018":[],"2019":[],"2020":[],"2021":[],"2022":[],"2023":[],"2024":[],"":["The aggregated values do not include data for all organizations. Customize this report by organization for details."]},"verifieds":{"2015":{"3":false,"1":false},"2016":{"1":false,"3":false},"2017":{"3":false,"1":false},"2018":{"1":false,"3":false},"2019":{"3":false,"1":false},"2020":{"12":false,"1":false,"3":false},"2021":{"3":false,"1":false,"12":false},"2022":{"3":false,"1":false,"12":false},"2023":{"12":false,"1":false,"3":false},"2024":{"3":false,"1":false,"12":false}},"measure":{"measure_id":"120419","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment","description":"

HEDIS\u00ae Measurement Description: The percentage of members 18 years of age and older who were treated with antidepressant medication, had a diagnosis of major depression and who remained on an antidepressant medication treatment. This measure reports Effective Acute Phase Treatment: <\/em>The percentage of members who remained on an antidepressant medication for at least 84 days (12 weeks).<\/p>","tech_definition":"

See HEDIS\u00ae Technical Specifications for Health Plans Volume 2 for the relevant measurement year.<\/p>","relevance":"

This measure captures the percent of adults 18 years of age and older who had a diagnosis of major depression, were prescribed antidepressant medication(s), and remained on medication treatment for at least 180 days (6 months). It is important that adults take the medication(s) as prescribed to obtain the full benefits. A low or falling rate may indicate that the adults are not taking antidepressant medication(s) as prescribed which may increase the chance of relapse. This measure is reported as the number of adults 18 years of age and older who had a diagnosis of major depression, were prescribed an antidepressant medication, and remained on their medication treatment for at least 180 days (6 months), divided by the total eligible population, as a percentage.<\/p>","tech_definition_owner_id":"2302","steward_id":"3","data_source":"6","rate_source":"1","rate_formula":"c:1|\/|c:2|*|100","parent_measure_id":"0","uploader_user_id":"51","submission_frequency":"4","reporting_period_min":"1420088400","reporting_period_max":"4102376400","last_modified":"1751904268","spec_id":"836","rate_precision":"1","rate_type":"1","steward_measure_id":"AMM","requirement_source":"Exhibit O","optional_exclusions":"

See HEDIS\u00ae Technical Specifications for Health Plans Volume 2 for the relevant measurement year.<\/p>","comments":"","subpopulation":"0","summary_of_changes":"

See HEDIS\u00ae Technical Specifications for Health Plans Volume 2 for the relevant measurement year.<\/p>","eligible_population":"

See HEDIS\u00ae Technical Specifications for Health Plans Volume 2 for the relevant measurement year.<\/p>","period_length":"1","submission_due_date_lag":"7","lag_unit":"Months","use_case":"1","short_name":"Antidepressant Medication Management: Effective Acute Phase Treatment","retired":"","period_length_multiplier":"1","submission_frequency_multiplier":"1","acknowledgements":"

HEDIS\u00ae is a registered trademark of the National Committee for Quality Assurance (NCQA).<\/p>","retired_reason":"","replaced_by":"","definitions":"","summarize":"0","rate_weighted":"0","frequency_name":"Years","period_length_name":"Years","data_source_name":"Administrative","rate_type_name":"Percent","yaxis_label":"","machine_name":"antidepressant-medication-management-amm-effective-acute-phase-treatment","show_mean":"0","attr_links":"","period_info":{"name":"Year","format":"Y","label_format":"Y","diff_name":"year","diff_format":"y","diff_mult":"1","maxperiods":16}},"aggregated":true,"init":false,"org_abbrevs":{"14":"FFS (CTS)","8":"MPAP","10":"FFS-PAP","1":"NHHF","3":"WS","12":"ACNH","16":"NEDD","4":"MFFS","11":"DHHS","13":"FFS (OC)","2":"Meri"},"ci":{"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment":[{"lower":"56.6","upper":"61.2"},{"lower":"54.2","upper":"59.0"},{"lower":"54.7","upper":"60.1"},{"lower":"51.9","upper":"57.5"},{"lower":"58.5","upper":"62.9"},{"lower":"59.3","upper":"62.7"},{"lower":"63.7","upper":"66.7"},{"lower":"64.9","upper":"67.9"},{"lower":"64.7","upper":"68.5"},{"lower":"67.1","upper":"71.5"}]},"statuses":{"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment":{"2015":{"6":"Published"},"2016":{"6":"Published"},"2017":{"6":"Published"},"2018":{"6":"Published"},"2019":{"6":"Published"},"2020":{"6":"Published"},"2021":{"6":"Published"},"2022":{"6":"Published"},"2023":{"6":"Published"},"2024":{"6":"Published"}}},"comptypes":{"2023":{"0":"1","4":"1","8":"1"}},"comppref":{"2023":{"0":">=","4":">=","8":">="}},"compsources":{"2023":{"0":"New England Medicaid Managed Care, Quality Compass, NCQA","4":"National Medicaid Managed Care, Quality Compass, NCQA","8":"NH Commercial"}},"compsuppress":{"2023":{"0":"1","4":"1","8":"0"}},"compmeasures":{"2023":[{"id":"120419","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},null,null,null,{"id":"120419","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},null,null,null,{"id":"120419","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},null,null,null],"2022":[null,{"id":"117067","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},null,null,null,{"id":"117067","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},null,null,null,{"id":"117067","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},null,null],"2021":[null,null,{"id":"114590","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},null,null,null,{"id":"114590","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},null,null,null,{"id":"114590","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},null],"2020":[null,null,null,{"id":"111891","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},null,null,null,{"id":"111891","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},null,null,null,{"id":"111891","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"}]}}},"template_options":{"template":"allinfo","trend_graph":true,"trend_type":"line","confidence":true,"comparator_graph":true,"data_tables":true,"submitted_data":true,"comparator_data":true,"data_source":true,"relevance":true,"topics":true,"description":true,"definitions":true,"tech_def":true,"data_elements":true,"eligible":true,"summary":true,"comparator_details":true},"filename":"Antidepressant_Medication_Management_(AMM)__Effective_Acute_Phase_Treatment","fixed_denom":2,"comp_goal":3,"generated":"Jul 16 2025 at 03:36","suppression_note":"Data has been suppressed due to small sample size."}}},"#theme":"mqis_measure_report_enhanced_template","#measures":{"117322":{"xcomps":{"2023":"2023"},"ycomps":{"2023":{"0":"65.6","4":"68.4","8":"78.0"}},"complegend":{"0":"New England Medicaid Managed Care CY 2023","4":"National Medicaid Managed Care 75th Percentile CY 2023","8":"NH Commercial CY 2023"},"compdata":{"Comparison Rate":[{"name":"New England Medicaid Managed Care","data_source":"New England Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"2","notes":"","year":"2023","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"New England Medicaid Managed Care","data_source":"New England Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"2","notes":"","year":"2023","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"New England Medicaid Managed Care","data_source":"New England Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"2","notes":"","year":"2022","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"New England Medicaid Managed Care","data_source":"New England Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"2","notes":"","year":"2021","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"New England Medicaid Managed Care","data_source":"New England Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"2","notes":"","year":"2020","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"New England Medicaid Managed Care","data_source":"New England Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"2","notes":"","year":"2020","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"National Medicaid Managed Care 75th Percentile","data_source":"National Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"3","notes":"","year":"2023","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"National Medicaid Managed Care 75th Percentile","data_source":"National Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"3","notes":"","year":"2023","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"National Medicaid Managed Care 75th Percentile","data_source":"National Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"3","notes":"","year":"2022","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"National Medicaid Managed Care 75th Percentile","data_source":"National Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"3","notes":"","year":"2021","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"National Medicaid Managed Care 75th Percentile","data_source":"National Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"3","notes":"","year":"2020","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"National Medicaid Managed Care 75th Percentile","data_source":"National Medicaid Managed Care, Quality Compass, NCQA","data_source_order":"3","notes":"","year":"2020","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"NH Commercial","data_source":"NH Commercial","data_source_order":"14","notes":"","year":"2023","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"NH Commercial","data_source":"NH Commercial","data_source_order":"14","notes":"","year":"2023","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"NH Commercial","data_source":"NH Commercial","data_source_order":"14","notes":"","year":"2022","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"NH Commercial","data_source":"NH Commercial","data_source_order":"14","notes":"","year":"2021","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"NH Commercial","data_source":"NH Commercial","data_source_order":"14","notes":"","year":"2020","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},{"name":"NH Commercial","data_source":"NH Commercial","data_source_order":"14","notes":"","year":"2020","year_type":"CY","measure_name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"}]},"ymax":115,"comp_table":"\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
Antidepressant Medication Management (AMM): Effective Acute Phase Treatment - Comparators (Export<\/a>)<\/span><\/caption>\n \n \n
Original Order\n \n Sort descending\n <\/span>\n<\/span>\n<\/a><\/th>\n Measure ID<\/a><\/th>\n Measure Name<\/a><\/th>\n Comparator Name<\/a><\/th>\n Comparator Type<\/a><\/th>\n Year<\/a><\/th>\n Value<\/a><\/th>\n <\/tr>\n <\/thead>\n \n
0<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n New England Medicaid Managed Care CY 2023<\/td>\n Comparison Rate<\/td>\n 2023<\/td>\n \u2021<\/td>\n <\/tr>\n
1<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n New England Medicaid Managed Care CY 2022<\/td>\n Comparison Rate<\/td>\n 2022<\/td>\n \u2021<\/td>\n <\/tr>\n
2<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n New England Medicaid Managed Care CY 2021<\/td>\n Comparison Rate<\/td>\n 2021<\/td>\n \u2021<\/td>\n <\/tr>\n
3<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n New England Medicaid Managed Care CY 2020<\/td>\n Comparison Rate<\/td>\n 2020<\/td>\n \u2021<\/td>\n <\/tr>\n
4<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n National Medicaid Managed Care 75th Percentile CY 2023<\/td>\n Comparison Rate<\/td>\n 2023<\/td>\n \u2021<\/td>\n <\/tr>\n
5<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n National Medicaid Managed Care 75th Percentile CY 2022<\/td>\n Comparison Rate<\/td>\n 2022<\/td>\n \u2021<\/td>\n <\/tr>\n
6<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n National Medicaid Managed Care 75th Percentile CY 2021<\/td>\n Comparison Rate<\/td>\n 2021<\/td>\n \u2021<\/td>\n <\/tr>\n
7<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n National Medicaid Managed Care 75th Percentile CY 2020<\/td>\n Comparison Rate<\/td>\n 2020<\/td>\n \u2021<\/td>\n <\/tr>\n
8<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n NH Commercial CY 2023<\/td>\n Comparison Rate<\/td>\n 2023<\/td>\n 78.0<\/td>\n <\/tr>\n
9<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n NH Commercial CY 2022<\/td>\n Comparison Rate<\/td>\n 2022<\/td>\n 77.2<\/td>\n <\/tr>\n
10<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n NH Commercial CY 2021<\/td>\n Comparison Rate<\/td>\n 2021<\/td>\n 81.0<\/td>\n <\/tr>\n
11<\/td>\n HEDIS_AMM.01.A<\/td>\n Antidepressant Medication Management (AMM): Effective Acute Phase Treatment<\/td>\n NH Commercial CY 2020<\/td>\n Comparison Rate<\/td>\n 2020<\/td>\n 70.0<\/td>\n <\/tr>\n <\/tbody>\n <\/table>\n","xseries":{"2015":"2015","2016":"2016","2017":"2017","2018":"2018","2019":"2019","2020":"2020","2021":"2021","2022":"2022","2023":"2023","2024":"2024"},"yseries":{"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment":{"2015":"58.9","2016":"56.6","2017":"57.4","2018":"54.7","2019":"60.7","2020":"61.0","2021":"65.2","2022":"66.4","2023":"66.6","2024":"69.3"}},"trendlegend":{"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment":"Total (All Subgroups)"},"numerators":{"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment":[1059,957,742,682,1125,1914,2647,2397,1596,1203]},"denominators":{"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment":[1799,1691,1293,1246,1852,3136,4062,3611,2395,1737]},"timeperiods":{"t_2015-01-01_2015-12-31":{"start":"1420088400","end":"1451538000"},"t_2016-01-01_2016-12-31":{"start":"1451624400","end":"1483160400"},"t_2017-01-01_2017-12-31":{"start":"1483246800","end":"1514696400"},"t_2018-01-01_2018-12-31":{"start":"1514782800","end":"1546232400"},"t_2019-01-01_2019-12-31":{"start":"1546318800","end":"1577768400"},"t_2020-01-01_2020-12-31":{"start":"1577854800","end":"1609390800"},"t_2021-01-01_2021-12-31":{"start":"1609477200","end":"1640926800"},"t_2022-01-01_2022-12-31":{"start":"1641013200","end":"1672462800"},"t_2023-01-01_2023-12-31":{"start":"1672549200","end":"1703998800"},"t_2024-01-01_2024-12-31":{"start":"1704085200","end":"1735621200"}},"data_elements":[{"data_element_id":"261044","identifier":"HEDIS_AMM.01.A_NUM","measure_id":"120419","type":"1","tech_definition":"

See HEDIS\u00ae Technical Specifications for Health Plans Volume 2 for the relevant measurement year.<\/p>","class":"1","uploader_user_id":"51","last_modified":"1705426429","spec_id":"836","data_element_class_name":"Numerator"},{"data_element_id":"261045","identifier":"HEDIS_AMM.01.A_DEN","measure_id":"120419","type":"1","tech_definition":"

See HEDIS\u00ae Technical Specifications for Health Plans Volume 2 for the relevant measurement year.<\/p>","class":"2","uploader_user_id":"51","last_modified":"1705426443","spec_id":"836","data_element_class_name":"Denominator"},{"data_element_id":"261046","identifier":"HEDIS_AMM.01.A_RATE","measure_id":"120419","type":"1","tech_definition":"

See HEDIS\u00ae Technical Specifications for Health Plans Volume 2 for the relevant measurement year.<\/p>","class":"3","uploader_user_id":"51","last_modified":"1705426457","spec_id":"836","data_element_class_name":"Rate"},{"data_element_id":"261047","identifier":"HEDIS_AMM.01.A_LCI","measure_id":"120419","type":"1","tech_definition":"

See HEDIS\u00ae Technical Specifications for Health Plans Volume 2 for the relevant measurement year.<\/p>","class":"4","uploader_user_id":"51","last_modified":"1705426471","spec_id":"836","data_element_class_name":"Lower Confidence Interval"},{"data_element_id":"261048","identifier":"HEDIS_AMM.01.A_UCI","measure_id":"120419","type":"1","tech_definition":"

See HEDIS\u00ae Technical Specifications for Health Plans Volume 2 for the relevant measurement year.<\/p>","class":"5","uploader_user_id":"51","last_modified":"1705426483","spec_id":"836","data_element_class_name":"Upper Confidence Interval"}],"data_table":"\n \n \n \n \n \n \n \n \n \n \n \n \n \n
Antidepressant Medication Management (AMM): Effective Acute Phase Treatment (Export<\/a>)<\/span><\/caption>\n \n \n
Time Period<\/th>\n Measure Name<\/th>\n Measure Numerator<\/th>\n Measure Denominator<\/th>\n Measure Rate<\/th>\n Confidence Interval<\/th>\n <\/tr>\n <\/thead>\n \n
2015-01-01 - 2015-12-31<\/td>\n Total (All Subgroups)<\/td>\n 1,059<\/td>\n 1,799<\/td>\n 58.9%<\/td>\n 56.6 - 61.2<\/td>\n <\/tr>\n
2016-01-01 - 2016-12-31<\/td>\n Total (All Subgroups)<\/td>\n 957<\/td>\n 1,691<\/td>\n 56.6%<\/td>\n 54.2 - 59.0<\/td>\n <\/tr>\n
2017-01-01 - 2017-12-31<\/td>\n Total (All Subgroups)<\/td>\n 742<\/td>\n 1,293<\/td>\n 57.4%<\/td>\n 54.7 - 60.1<\/td>\n <\/tr>\n
2018-01-01 - 2018-12-31<\/td>\n Total (All Subgroups)<\/td>\n 682<\/td>\n 1,246<\/td>\n 54.7%<\/td>\n 51.9 - 57.5<\/td>\n <\/tr>\n
2019-01-01 - 2019-12-31<\/td>\n Total (All Subgroups)<\/td>\n 1,125<\/td>\n 1,852<\/td>\n 60.7%<\/td>\n 58.5 - 62.9<\/td>\n <\/tr>\n
2020-01-01 - 2020-12-31<\/td>\n Total (All Subgroups)<\/td>\n 1,914<\/td>\n 3,136<\/td>\n 61.0%<\/td>\n 59.3 - 62.7<\/td>\n <\/tr>\n
2021-01-01 - 2021-12-31<\/td>\n Total (All Subgroups)<\/td>\n 2,647<\/td>\n 4,062<\/td>\n 65.2%<\/td>\n 63.7 - 66.7<\/td>\n <\/tr>\n
2022-01-01 - 2022-12-31<\/td>\n Total (All Subgroups)<\/td>\n 2,397<\/td>\n 3,611<\/td>\n 66.4%<\/td>\n 64.9 - 67.9<\/td>\n <\/tr>\n
2023-01-01 - 2023-12-31<\/td>\n Total (All Subgroups)<\/td>\n 1,596<\/td>\n 2,395<\/td>\n 66.6%<\/td>\n 64.7 - 68.5<\/td>\n <\/tr>\n
2024-01-01 - 2024-12-31<\/td>\n Total (All Subgroups)<\/td>\n 1,203<\/td>\n 1,737<\/td>\n 69.3%<\/td>\n 67.1 - 71.5<\/td>\n <\/tr>\n <\/tbody>\n <\/table>\n","suppressed":false,"orgs":{"MCM: AmeriHealth Caritas NH":12,"MCM: NH Healthy Families":1,"MCM: Well Sense":3,"MCM: Meridian":2},"qualifiers":{"2015":[],"2016":[],"2017":[],"2018":[],"2019":[],"2020":[],"2021":[],"2022":[],"2023":[],"2024":[],"":["The aggregated values do not include data for all organizations. Customize this report by organization for details."]},"verifieds":{"2015":{"3":false,"1":false},"2016":{"1":false,"3":false},"2017":{"3":false,"1":false},"2018":{"1":false,"3":false},"2019":{"3":false,"1":false},"2020":{"12":false,"1":false,"3":false},"2021":{"3":false,"1":false,"12":false},"2022":{"3":false,"1":false,"12":false},"2023":{"12":false,"1":false,"3":false},"2024":{"3":false,"1":false,"12":false}},"measure":{"measure_id":"120419","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment","description":"

HEDIS\u00ae Measurement Description: The percentage of members 18 years of age and older who were treated with antidepressant medication, had a diagnosis of major depression and who remained on an antidepressant medication treatment. This measure reports Effective Acute Phase Treatment: <\/em>The percentage of members who remained on an antidepressant medication for at least 84 days (12 weeks).<\/p>","tech_definition":"

See HEDIS\u00ae Technical Specifications for Health Plans Volume 2 for the relevant measurement year.<\/p>","relevance":"

This measure captures the percent of adults 18 years of age and older who had a diagnosis of major depression, were prescribed antidepressant medication(s), and remained on medication treatment for at least 180 days (6 months). It is important that adults take the medication(s) as prescribed to obtain the full benefits. A low or falling rate may indicate that the adults are not taking antidepressant medication(s) as prescribed which may increase the chance of relapse. This measure is reported as the number of adults 18 years of age and older who had a diagnosis of major depression, were prescribed an antidepressant medication, and remained on their medication treatment for at least 180 days (6 months), divided by the total eligible population, as a percentage.<\/p>","tech_definition_owner_id":"2302","steward_id":"3","data_source":"6","rate_source":"1","rate_formula":"c:1|\/|c:2|*|100","parent_measure_id":"0","uploader_user_id":"51","submission_frequency":"4","reporting_period_min":"1420088400","reporting_period_max":"4102376400","last_modified":"1751904268","spec_id":"836","rate_precision":"1","rate_type":"1","steward_measure_id":"AMM","requirement_source":"Exhibit O","optional_exclusions":"

See HEDIS\u00ae Technical Specifications for Health Plans Volume 2 for the relevant measurement year.<\/p>","comments":"","subpopulation":"0","summary_of_changes":"

See HEDIS\u00ae Technical Specifications for Health Plans Volume 2 for the relevant measurement year.<\/p>","eligible_population":"

See HEDIS\u00ae Technical Specifications for Health Plans Volume 2 for the relevant measurement year.<\/p>","period_length":"1","submission_due_date_lag":"7","lag_unit":"Months","use_case":"1","short_name":"Antidepressant Medication Management: Effective Acute Phase Treatment","retired":"","period_length_multiplier":"1","submission_frequency_multiplier":"1","acknowledgements":"

HEDIS\u00ae is a registered trademark of the National Committee for Quality Assurance (NCQA).<\/p>","retired_reason":"","replaced_by":"","definitions":"","summarize":"0","rate_weighted":"0","frequency_name":"Years","period_length_name":"Years","data_source_name":"Administrative","rate_type_name":"Percent","yaxis_label":"","machine_name":"antidepressant-medication-management-amm-effective-acute-phase-treatment","show_mean":"0","attr_links":"","period_info":{"name":"Year","format":"Y","label_format":"Y","diff_name":"year","diff_format":"y","diff_mult":"1","maxperiods":16}},"aggregated":true,"init":false,"org_abbrevs":{"14":"FFS (CTS)","8":"MPAP","10":"FFS-PAP","1":"NHHF","3":"WS","12":"ACNH","16":"NEDD","4":"MFFS","11":"DHHS","13":"FFS (OC)","2":"Meri"},"ci":{"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment":[{"lower":"56.6","upper":"61.2"},{"lower":"54.2","upper":"59.0"},{"lower":"54.7","upper":"60.1"},{"lower":"51.9","upper":"57.5"},{"lower":"58.5","upper":"62.9"},{"lower":"59.3","upper":"62.7"},{"lower":"63.7","upper":"66.7"},{"lower":"64.9","upper":"67.9"},{"lower":"64.7","upper":"68.5"},{"lower":"67.1","upper":"71.5"}]},"statuses":{"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment":{"2015":{"6":"Published"},"2016":{"6":"Published"},"2017":{"6":"Published"},"2018":{"6":"Published"},"2019":{"6":"Published"},"2020":{"6":"Published"},"2021":{"6":"Published"},"2022":{"6":"Published"},"2023":{"6":"Published"},"2024":{"6":"Published"}}},"comptypes":{"2023":{"0":"1","4":"1","8":"1"}},"comppref":{"2023":{"0":">=","4":">=","8":">="}},"compsources":{"2023":{"0":"New England Medicaid Managed Care, Quality Compass, NCQA","4":"National Medicaid Managed Care, Quality Compass, NCQA","8":"NH Commercial"}},"compsuppress":{"2023":{"0":"1","4":"1","8":"0"}},"compmeasures":{"2023":[{"id":"120419","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},null,null,null,{"id":"120419","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},null,null,null,{"id":"120419","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},null,null,null],"2022":[null,{"id":"117067","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},null,null,null,{"id":"117067","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},null,null,null,{"id":"117067","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},null,null],"2021":[null,null,{"id":"114590","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},null,null,null,{"id":"114590","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},null,null,null,{"id":"114590","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},null],"2020":[null,null,null,{"id":"111891","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},null,null,null,{"id":"111891","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"},null,null,null,{"id":"111891","identifier":"HEDIS_AMM.01.A","name":"Antidepressant Medication Management (AMM): Effective Acute Phase Treatment"}]}}},"#template_options":{"template":"allinfo","trend_graph":true,"trend_type":"line","confidence":true,"comparator_graph":true,"data_tables":true,"submitted_data":true,"comparator_data":true,"data_source":true,"relevance":true,"topics":true,"description":true,"definitions":true,"tech_def":true,"data_elements":true,"eligible":true,"summary":true,"comparator_details":true},"#filename":"Antidepressant_Medication_Management_(AMM)__Effective_Acute_Phase_Treatment","#description":"","#header_links":"","#footer":"

Master Export<\/a> (all data for the reported measures as a csv file)<\/span><\/p>

Report Details<\/h3>

Generated on Jul 16 2025 at 03:36
Measures: Antidepressant Medication Management (AMM): Effective Acute Phase Treatment
Max Time Periods: 16
Organizations: All (aggregated)
Data Publish Statuses: Published<\/p>

Data Qualifiers:<\/p>